Company news

Anagenics Limited news in 2016

Anagenics Limited's news releases, calls and decks from 2016, newest first.

View company

Cellmid Updates on CxBladder License

December 12, 2016

Cellmid receives 831K R&D tax credit

November 29, 2016

USA launch of evolis

November 2, 2016

Cellmid: Appendix 3Y- Change of Director’s Interest Notice

November 1, 2016

ASX Market Release - Reinstatement

October 31, 2016

Cellmid records highest ever quarterly sales for evolis

October 10, 2016

Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer

October 5, 2016

European Midkine Patent For Surgical Adhesion Allowed

September 22, 2016

New Publication for Cellmids Midkine Antibody

August 9, 2016

Transcript of Cellmid Investor Briefing Call

July 29, 2016

CDY: Ikon Legal Action

July 22, 2016

USA Distribution Partnership for Cellmids Evolis

July 19, 2016

MK antibody publication and patent in bone healing

June 24, 2016

Midkine Strategy Update

April 8, 2016

Response to ASX Query

March 30, 2016

Cellmid to Refinance RnD Loan

February 26, 2016

Cellmid receives $1.12M R&D Tax Credit

February 11, 2016

Key Antibody Patent Granted in Europe

February 10, 2016

Decks in 2016